About SSI Strategy
SSI Strategy is a Healthcare company based in Parsippany Troy Hills (United States) founded in 2010, and was acquired by Clinigen in September 2025. Pharmacovigilance and medical affairs services are offered for drug development. SSI Strategy has completed 3 acquisitions, including Fiore Healthcare Advisors, NDA Group and Scientific Advantage. SSI Strategy offers products and services including Strategic Medical Office, Translational & Clinical Development, Clinical Operations, Regulatory Affairs, and Quality & Compliance. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is SSI Strategy LLC.
Company details
SSI Strategy was founded in 2010 and is based in Parsippany Troy Hills, United States. Services in medical affairs, pharmacovigilance, and clinical development are provided to emerging, mid-size, and global pharmaceutical and biotech companies. Offerings include global medical affairs transformation, post-merger integration, launch preparation, pharmacovigilance system enhancements, medical planning, tactic prioritization, and emerging markets support. Scientific Advantage was acquired in October 2016 to broaden medical affairs capabilities.
- Headquarters Parsippany Troy Hills, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ssistrategy.com
- Social LinkedIn X
- Acquired by HGGC (Dec 2014)
- Legal Name Ssi Strategy Llc
- InvestorsClinigen
& 2 more
- Investments & AcquisitionsFiore Healthcare Advisors
& 2 more
- Acquired by
Products & Services of SSI Strategy
SSI Strategy offers a comprehensive portfolio of products and services, including Strategic Medical Office, Translational & Clinical Development, Clinical Operations, Regulatory Affairs, and Quality & Compliance.
Ensures scientific integrity and stakeholder engagement
Innovates therapies through patient-centric approaches
Provides leadership for trial execution and excellence
Offers strategies for successful drug approvals
Accelerates success via strategic oversight
Funding Insights of SSI Strategy
- Total Rounds 2
- Investors Count 1
All 2 funding rounds of SSI Strategy with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2020 | Debt – Conventional | – | – | ||
| Dec 2020 | Private Equity Round | – | Amulet Capital Partners | – |
3 investors in total: 3 institutional.
Investors in SSI Strategy
SSI Strategy has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Clinigen, Amulet Capital and HGGC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Amulet Capital is focused on healthcare private equity investments. | amuletcapital.com | Greenwich, United States | ||
Private equity firm focused on middle market investments. | hggc.com | |||
Specialty medicines are supplied via clinical trials and access programs. | 2010 | clinigengroup.com | Burton-on-trent, United Kingdom |
Investor details for SSI Strategy
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SSI Strategy
34 people are tracked at SSI Strategy (30 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Jacqui Levine | Senior Vice President | Leadership |
Maxwell Craig | Senior Vice President | Leadership |
Doug Locke | CEO | Leadership |
Adam Schwartz | President | Leadership |
Madhav Gurijala | Senior Vice President | Leadership |
Kim Kushner | Chief Business Officer | Leadership |
Sara Chan | Vice President | Leadership |
Niklas Bendelius | Vice President Information Technology | Leadership |
Adriana Valenciano | Senior Vice President | Leadership |
Joseph Massey | Vice President | Leadership |
Craig Ungaro | CFO | Leadership |
Amit Patel | Senior Vice President, Medical | Leadership |
Delphine Moreau | Executive Vice President, Medical Services | Leadership |
Robert Honigberg | Vice President And Medical/surgical Lead | Leadership |
Cynthia Wetmore | Vice President, Medicine And Clinical Development | Leadership |
Simon Kennedy | Managing Director | Leadership |
Erica Lindewald | Vice President, Global People & Culture | Leadership |
Kerby Houff | Senior Vice President | Leadership |
Kate Goldstein | Senior Vice President | Leadership |
Dr. Len Walt M.D. | VP Medical | Leadership |
14 more people are available in the full profile.
Complete people profiles for SSI Strategy
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SSI Strategy
SSI Strategy has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Fiore Healthcare Advisors, NDA Group and Scientific Advantage.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Regulatory, pharmacovigilance and quality assurance services | ndareg.com | Upplands Vasby, Sweden | 1997 | Aug 2023 | •••• | |
Provider of data safety review, auditing, and other consulting services | fiorehealthcare.com | Boston, United States | 2014 | Jun 2021 | •••• | |
Medical affairs solutions including training and compliance services are offered. | scientificadvantage.com | Parsippany Troy Hills, United States | 2002 | Oct 2016 | •••• |
Complete acquisition details for SSI Strategy
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of SSI Strategy
7 dated milestones of SSI Strategy across 15 years, from founding to its latest funding, stage changes and deals.
- Founded SSI Strategy is founded.
- Exit Acquired by HGGC.
- Acquisition Acquires Scientific Advantage.
- Funding First funding round.
- Acquisition Acquires Fiore Healthcare Advisors.
- Acquisition Acquires NDA Group.
- Exit Acquired by Clinigen.
Web traffic of SSI Strategy
The website of SSI Strategy (ssistrategy.com) receives about 3K visits a month.
- Monthly visits3K
▼ 17.1% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as SSI Strategy (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ssi Strategy
Complete news archive for SSI Strategy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SSI Strategy
SSI Strategy was founded in 2010 and raised its 1st funding round 10 years after it was founded.
SSI Strategy is headquartered in Parsippany Troy Hills, United States. It is registered at Parsippany Troy Hills, New Jersey, United States.
SSI Strategy was founded in 2010 and is based in Parsippany Troy Hills, United States. Services in medical affairs, pharmacovigilance, and clinical development are provided to emerging, mid-size, and global pharmaceutical and biotech companies. Offerings include global medical affairs transformation, post-merger integration, launch preparation, pharmacovigilance system enhancements, medical planning, tactic prioritization, and emerging markets support. Scientific Advantage was acquired in October 2016 to broaden medical affairs capabilities.
SSI Strategy offers Strategic Medical Office, Translational & Clinical Development, Clinical Operations, Regulatory Affairs, and Quality & Compliance.
SSI Strategy has made 3 acquisitions, including Fiore Healthcare Advisors, NDA Group, and Scientific Advantage.
SSI Strategy has 3 investors. Key investors include Clinigen, Amulet Capital, and HGGC.
SSI Strategy operates through Ssi Strategy Llc.
Yes. SSI Strategy was acquired by HGGC in December 2014.